Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/31/24 17:00 | 10/31/24 | SCND | Electr | LabEq | Laboratory Analytical Instrum | Moore John A | DE | DO | CB | 5 | P.d | 128 | 1.78 | 0 | 72 | 18 | 480 | D | ||||||||||||||
7/31/24 16:55 | 12/13/23 | SCND | Electr | LabEq | Laboratory Analytical Instrum | Nicols John J | LA | D | 1 | P.d | 30 | 2.00 | 0 | 15 | 15 | D | ||||||||||||||||
6/28/24 17:13 | 12/19/23 | SCND | Electr | LabEq | Laboratory Analytical Instrum | Cox Christopher T | NY | D | 1 | P.d | 158 | 2.00 | 0 | 79 | 36 | 301 | D | |||||||||||||||
1/29/24 12:06 | 1/17/24 | SCND | Electr | LabEq | Laboratory Analytical Instrum | Santos Helena R | DO | CEO,P | 1 | P.d | 0 | 2.00 | 0 | 0 | 0 | 258 | D | |||||||||||||||
1/17/24 16:48 | 12/13/23 | SCND | Electr | LabEq | Laboratory Analytical Instrum | Frampton Marcus | AK | T | 1 | P.d | 55 | 2.00 | 0 | 28 | 25 | 136 | D | |||||||||||||||
12/15/23 16:39 | 12/13/23 | SCND | Electr | LabEq | Laboratory Analytical Instrum | Bleichroeder LP | NY | T | 1 | P.d | 1,200 | 2.00 | 0 | 600 | 99 | 1,203 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |